Appello Pharmaceuticals
- Website
- appellopharma.com
- Total Funding
- $24.0M
- Last Round
- $13.5M Series BJun 2018
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Appello Pharmaceuticals is a Biotech company. It has raised $24.0M in total across 2 rounds, most recently a $13.5M Series B round in Jun 2018. Investors include Deerfield Management, Mountain Partners and Alexandria Venture Investments.
Funding History
Jun 2018
Sign up to see all 2 events
Funding: Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/appello-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/appello-pharmaceuticals" alt="Appello Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>


